LifeMD, Inc. — Key Metrics
2 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Turnover & Efficiency Analysis (days)
Expense Ratios
Working Capital Analysis
Valuation Multiples
Cash-Flow Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
Liquidity & Leverage Ratios
Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)
EPS (Diluted)
$0
Book Value Per Share
$1
Free Cash Flow Per Share
$0
Cash Per Share
$1
Revenue Per Share
$4
OCF Per Share
$0
Return on Equity
204.0%
Return on Assets
19.6%
Return on Invested Capital
-86.1%
Current Ratio
1.25
Quick Ratio
1.18
Asset Turnover
2.65
Days Sales Outstanding
17.50
Days Payables Outstanding
186.34
Days Inventory On Hand
36.53
Cash Conversion Cycle
-132.31
R&D / Revenue
—
SBC / Revenue
5.4%
Capex / Revenue
1.0%
Working Capital
$10M
Net Current Asset Value
$5M
Invested Capital
$23M
OCF / Net Income
0.58
FCF / Net Income
0.45
Accruals Ratio (Sloan)
8.6%
Net Debt
$-35M
Net Debt / EBITDA
1.76
Interest Coverage
-5.64
Cash Coverage
6.08
Dividend Coverage
2.67
Capex Coverage
4.43
Tangible Common Equity
$23M
TCE / Total Assets
32.5%
Goodwill / Total Assets
—
NOPAT
$-6M
Cash ROIC
91.1%
WC / Revenue
5.3%
Capex / D&A
2.16
Reinvestment Rate
-13.1%
Total Payout Ratio
23.5%
Asset Growth vs Revenue Growth
-32.8%
Revenue 5Y CAGR
39.1%
FCF 5Y CAGR
129.6%
Book Value 5Y CAGR
—
Stock Price (FY-end)
$3
Market Cap
$154M
P/E Ratio
10.72
P/S Ratio
0.79
P/B Ratio
6.65
P/TB Ratio
6.72
P/OCF Ratio
18.59
P/FCF Ratio
24.01
Enterprise Value
$154M
EV / Sales
0.79
EV / FCF
24.01
FCF Yield
4.2%
Dividend Yield
2.0%
Shareholder Yield
-4.6%
Buyback Yield
0.2%
R&D Yield
—
Capex Yield
1.2%
Dividend Per Share
$0
DPS YoY Growth
-8.7%
Graham Number
$2
Shares Variation (YoY)
9.5%
Beta (5Y)
1.59
Cost of Equity
12.5%
52W High
$15
52W Low
$3
Trailing Return 1Y
-34.7%
Trailing Return 5Y
-53.3%
F-Score (Piotroski)
5.00
Z-Score (Altman)
-0.02
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.